TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9187063

Group type: EXPERIMENTAL
Intervention: Presentation of the minor premise (not‐q) as the initial premise in modus tollens arguments.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inversion of the premise order in modus ponens arguments.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Facilitation conditions in modus tollens arguments (Experiments 3 and 4).
Number of subjects: 0

Group type: COMPARATOR
Intervention: Explicitly stating the not‐q case from the start (Experiments 5 and 6).
Number of subjects: 0

Group type: COMPARATOR
Intervention: Premise order in conditional fallacies (Experiments 7 and 8).
Number of subjects: 0
Study: 1493631

Group type: EXPERIMENTAL
Intervention: Intranasal splints
Number of subjects: 105

Group type: COMPARATOR
Intervention: Careful nasal toilet at one week
Number of subjects: 105
Study: 4024649

Group type: EXPERIMENTAL
Intervention: Lithium therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 31265080

Group type: EXPERIMENTAL
Intervention: Levofloxacin prophylaxis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 29332308

Group type: EXPERIMENTAL
Intervention: Percutaneous PFO closure
Number of subjects: 3440

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 3440
Study: 27305952

Group type: EXPERIMENTAL
Intervention: Regular meal pattern (6 meals/d)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Irregular meal pattern (3-9 meals/d)
Number of subjects: 11
Study: 24452818

Group type: EXPERIMENTAL
Intervention: Training sessions (1 or 2) for each method of brief preference assessments
Number of subjects: 9
Study: 22480341

Group type: EXPERIMENTAL
Intervention: Consultation-based intervention delivered by clinic nurse
Number of subjects: 211

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 211
Study: 21210338

Group type: EXPERIMENTAL
Intervention: Zolpidem (0.14-0.2 mg/kg daily for 4 days)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo (daily for 4 days)
Number of subjects: 3
Study: 17907489

Group type: EXPERIMENTAL
Intervention: Hybrid Bond
Number of subjects: 60

Group type: COMPARATOR
Intervention: Admira Bond
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clearfil SE Bond
Number of subjects: 60
Study: 15071980

Group type: EXPERIMENTAL
Intervention: Presentation of clinical test results as relative risk reduction
Number of subjects: 96

Group type: COMPARATOR
Intervention: Presentation of clinical test results as number needed to treat
Number of subjects: 96
Study: 11152917

Group type: COMPARATOR
Intervention: 0.625 mg of estrone sulfate + placebo
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: 0.625 mg of estrone sulfate + 2.5 mg medroxyprogesterone acetate
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: 0.625 mg of estrone sulfate + 5 mg medroxyprogesterone acetate
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: 0.625 mg of estrone sulfate + 10 mg medroxyprogesterone acetate
Number of subjects: 682
Study: 9421657

Group type: EXPERIMENTAL
Intervention: 1.5 pitch low mA helical CT
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional high mA CT
Number of subjects: 25
Study: 7718382

Group type: EXPERIMENTAL
Intervention: Mivacurium 0.15 mg kg‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mivacurium 0.2 mg kg‐1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atracurium 0.5 mg kg‐1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atracurium
Number of subjects: 0
Study: 2715550

Group type: EXPERIMENTAL
Intervention: Indomethacin (100 mg/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: COMPARATOR
Intervention: Baseline (no treatment)
Number of subjects: 14
Study: 95729

Group type: EXPERIMENTAL
Intervention: Intranasal luteinising-hormone releasing hormone (L.H.R.H.) administered in six doses daily (1.2 mg/day) for four weeks
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 31868151

Group type: EXPERIMENTAL
Intervention: FDG PET/CT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional imaging methods
Number of subjects: 0
Study: 31158239

Group type: EXPERIMENTAL
Intervention: R. pomonella
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: R. indifferens
Number of subjects: 61
Study: 27694436

Group type: EXPERIMENTAL
Intervention: CHW face-to-face (F2F)
Number of subjects: 707

Group type: COMPARATOR
Intervention: CHW quitline (QL)
Number of subjects: 707
Study: 25622080

Group type: EXPERIMENTAL
Intervention: Genomic risk information (genetic test/family history)
Number of subjects: 1057

Group type: EXPERIMENTAL
Intervention: Health literacy
Number of subjects: 1057
Study: 23429094

Group type: EXPERIMENTAL
Intervention: Bright light treatment
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo session (deactivated ion generator)
Number of subjects: 34
Study: 20666669

Group type: EXPERIMENTAL
Intervention: 532-nm KTP laser irradiation
Number of subjects: 16

Group type: COMPARATOR
Intervention: 1064-nm Nd:YAG laser
Number of subjects: 16
Study: 19309606

Group type: EXPERIMENTAL
Intervention: Minimally invasive dynamic hip screw (MIDHS) fixation
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional dynamic hip screw (CDHS) fixation
Number of subjects: 66
Study: 17186205

Group type: EXPERIMENTAL
Intervention: Patients with access to electronic communication with their GP for a year
Number of subjects: 199

Group type: COMPARATOR
Intervention: Patients without access to electronic communication with their GP
Number of subjects: 199
Study: 16213287

Group type: EXPERIMENTAL
Intervention: sirolimus + prednisolone
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: sirolimus + mycophenolate mofetil + prednisolone
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: sirolimus + cyclosporine + prednisolone
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: sirolimus
Number of subjects: 21
Study: 11962682

Group type: EXPERIMENTAL
Intervention: Chronomodulated chemotherapy (B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard flat chemotherapy (A)
Number of subjects: 0
Study: 10075386

Group type: EXPERIMENTAL
Intervention: Sleep deprivation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Full night's sleep
Number of subjects: 36
Study: 7734897

Group type: EXPERIMENTAL
Intervention: Short-term initial hospital stay (23 +/- 4 days)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Long-term initial hospital stay (9 +/- 3 days)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Short-term initial hospital stay
Number of subjects: 61

Group type: COMPARATOR
Intervention: Long-term initial hospital stay
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Short-term treatment
Number of subjects: 61
Study: 2246042

Group type: EXPERIMENTAL
Intervention: Prenatal iron supplements (oral or parenteral)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parenteral iron
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral iron
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 0
Study: 556551

Group type: EXPERIMENTAL
Intervention: Cyclic polychemotherapy (cyclophosphamide, mercaptopurine, prednisolone, dipyridamol, heparin)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Continuous two-drug regimen (mercaptopurine + prednisolone)
Number of subjects: 55
Study: 30019072

Group type: EXPERIMENTAL
Intervention: Vertical incision
Number of subjects: 84

Group type: COMPARATOR
Intervention: Oblique incision
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study: 27848252

Group type: EXPERIMENTAL
Intervention: Decision Aid (DA)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Brochures
Number of subjects: 36
Study: 25881677

Group type: EXPERIMENTAL
Intervention: Sumatriptan/Naproxen Sodium (S/NS) 85/500 mg
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 24040080

Group type: EXPERIMENTAL
Intervention: Real TMS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 0
Study: 21359633

Group type: EXPERIMENTAL
Intervention: Complex intervention program to prevent disruptive behavior without using restrictive means
Number of subjects: 0
Study: 19686744

Group type: EXPERIMENTAL
Intervention: Minimal hepatic encephalopathy (mHE)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Overt hepatic encephalopathy grade I (oHE)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: No hepatic encephalopathy (HE0)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Self-evaluation questionnaire for mHE and oHE patients
Number of subjects: 51
Study: 17873259

Group type: EXPERIMENTAL
Intervention: Numeric, verbal, and visual formats of conveying health risks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 14982688

Group type: EXPERIMENTAL
Intervention: Bupropion hydrochloride sustained-release (Zyban)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 336
Study: 11300658

Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Irbesartan (various doses: 5, 25, 50, 75, 100, 150, or 300 mg)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 42
Study: 9428465

Group type: EXPERIMENTAL
Intervention: Predialysis blood draw
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: Postdialysis blood draw
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: Dilution of predialysis sample with heparin or saline
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: Presence of access-derived, recirculated blood in postdialysis sample
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: Excessive delay in drawing postdialysis sample
Number of subjects: 15000

Group type: EXPERIMENTAL
Intervention: Uniform blood sample draw procedure
Number of subjects: 15000
Study: 7978469

Group type: COMPARATOR
Intervention: Succinylcholine (1 mg/kg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.4 mg/kg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.8 mg/kg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Rocuronium 1.2 mg/kg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Succinylcholine
Number of subjects: 48
Study: 2688507

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEpo) at 300 or 150 U/kg body weight, reduced to 75 U/kg
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEpo) therapy
Number of subjects: 333
Study: 985045

Group type: EXPERIMENTAL
Intervention: Stressful events (both positive and negative valence)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stressful events (positive emotions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stressful events (dysphoric affects)
Number of subjects: 0
Study: 31490376

Group type: EXPERIMENTAL
Intervention: ICG combined with carbon nanoparticles (CNs)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Only carbon nanoparticles (CNs)
Number of subjects: 100
Study: 28215212

Group type: EXPERIMENTAL
Intervention: Palm oil (PO) meal
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Rice bran meal
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Coconut oil meal
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isoenergetic meals
Number of subjects: 40
Study: 25745071

Group type: EXPERIMENTAL
Intervention: Biventricular defibrillator (CRT-D)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Implantable single or dual-chamber defibrillator (ICD)
Number of subjects: 74
Study: 23768736

Group type: EXPERIMENTAL
Intervention: Aerochamber with Combivent (200 mcg salbutamol and 20 mcg ipratropium per puff)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Nebulizer with Combivent (2.5 mg salbutamol and 250 mcg ipratropium per mL)
Number of subjects: 41
Study: 21594832

Group type: EXPERIMENTAL
Intervention: Hybrid coronary artery revascularisation (HCR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard surgical revascularisation (CABG)
Number of subjects: 0
Study: 20166337

Group type: EXPERIMENTAL
Intervention: Combined physician-plus-patient intervention
Number of subjects: 417

Group type: COMPARATOR
Intervention: Physician-only intervention
Number of subjects: 417
Study: 16384759

Group type: EXPERIMENTAL
Intervention: Combination clindamycin (1%) and tretinoin (0.025%) hydrogel
Number of subjects: 2219

Group type: COMPARATOR
Intervention: Clindamycin
Number of subjects: 2219

Group type: COMPARATOR
Intervention: Tretinoin
Number of subjects: 2219

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 2219
Study: 15597653

Group type: EXPERIMENTAL
Intervention: Totally tubeless PCNL
Number of subjects: 43

Group type: COMPARATOR
Intervention: PCNL with ureteral stent and nephrostomy tube
Number of subjects: 43
Study: 11397861

Group type: EXPERIMENTAL
Intervention: rhLH (5,000, 15,000, 30,000, or 15,000 + 10,000 IU)
Number of subjects: 259

Group type: COMPARATOR
Intervention: u-hCG (5,000 IU)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: rhLH (up to 30,000 IU)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: rhLH (15,000 to 30,000 IU)
Number of subjects: 259
Study: 9024024

Group type: EXPERIMENTAL
Intervention: Needle aperture oriented in a cephalad direction (Group I)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Needle aperture directed caudally (Group II)
Number of subjects: 40
Study: 8360134

Group type: EXPERIMENTAL
Intervention: Oral fluconazole (50 mg/day as a single dose)
Number of subjects: 536

Group type: COMPARATOR
Intervention: Oral polyenes (amphotericin B 2 g/day and/or nystatin 4 x 10(6) units/day in four or more divided doses)
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Oral fluconazole
Number of subjects: 536

Group type: COMPARATOR
Intervention: Oral polyenes
Number of subjects: 536
Study: 3090906

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG) at doses up to 40 micrograms X kg‐1 X min‐1
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP) at doses of 6‐8 micrograms X kg‐1 X min‐1
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both NTG and SNP
Number of subjects: 14
Study: 31465156

Group type: EXPERIMENTAL
Intervention: Tai Chi therapy (Sun style Tai Chi exercise, 5 min warm-up, 45 min main exercise, 10 min meditation, conducted twice a week for 40 sessions over 5 months)
Number of subjects: 104
Study: 29229363

Group type: EXPERIMENTAL
Intervention: Flaxseed oil (FO), 25 mL/d
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sunflower seed oil (SO), 25 mL/d
Number of subjects: 60
Study: 26945711

Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atazanavir/ritonavir triple therapy
Number of subjects: 0
Study: 24304412

Group type: EXPERIMENTAL
Intervention: Slow-release oral morphine (SROM)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 157

Group type: COMPARATOR
Intervention: SROM and Methadone
Number of subjects: 157
Study: 21633047

Group type: COMPARATOR
Intervention: Standard-dose XT (capecitabine 1250 mg/m² twice daily, days 1-14; docetaxel 75 mg/m², day 1 every 3 weeks)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Low-dose XT (capecitabine 825 mg/m² twice daily, days 1-14; docetaxel as above)
Number of subjects: 470
Study: 20731878

Group type: EXPERIMENTAL
Intervention: Topical phenytoin 0.5%
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cream (control)
Number of subjects: 100
Study: 19008797

Group type: EXPERIMENTAL
Intervention: Neuromidin
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 15875094

Group type: EXPERIMENTAL
Intervention: Direct access DXA scanning (DADS)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Referral to a hospital consultant
Number of subjects: 325
Study: 12867219

Group type: EXPERIMENTAL
Intervention: L-carnitine (1 tablet BID)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 11955025

Group type: EXPERIMENTAL
Intervention: Multivariable model involving readily available clinical variables
Number of subjects: 2903

Group type: COMPARATOR
Intervention: 2-hour glucose value alone
Number of subjects: 2903

Group type: EXPERIMENTAL
Intervention: Multivariable model with 2-hour glucose measurement
Number of subjects: 2903
Study: 9734494

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 529

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 529

Group type: EXPERIMENTAL
Intervention: Tacrolimus (for hepatitis C-positive patients)
Number of subjects: 529

Group type: COMPARATOR
Intervention: Cyclosporine (for hepatitis C-positive patients)
Number of subjects: 529
Study: 8166033

Group type: EXPERIMENTAL
Intervention: Mylanta Cherry Creme
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mylanta Double Strength Cool Mint Creme
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Riopan Plus 2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Di‐Gel Lemon Orange
Number of subjects: 30
Study: 2975204

Group type: EXPERIMENTAL
Intervention: Procaterol (0.1 mg orally, twice daily)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Salbutamol (4 mg orally, 3-times a day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31135883

Group type: EXPERIMENTAL
Intervention: Omit NRTIs
Number of subjects: 360

Group type: COMPARATOR
Intervention: Add NRTIs
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Optimized regimen including NRTIs (for highly resistant group)
Number of subjects: 360
Study: 31205205

Group type: EXPERIMENTAL
Intervention: Pesticide safety curriculum
Number of subjects: 127

Group type: COMPARATOR
Intervention: Attention placebo-controlled curriculum (heat illness)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Heat illness curriculum
Number of subjects: 127
Study: 28857895

Group type: EXPERIMENTAL
Intervention: Cap-assisted water exchange (CWE)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Water exchange (WE)
Number of subjects: 120
Study: 25937155

Group type: EXPERIMENTAL
Intervention: Single incision laparoscopic varicocelectomy (SIL‐V)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional transperitoneal varicocelectomy (CTL‐V)
Number of subjects: 80
Study: 24135218

Group type: EXPERIMENTAL
Intervention: Combination of angiotensin‐converting enzyme inhibitor and angiotensin receptor blocker
Number of subjects: 103

Group type: COMPARATOR
Intervention: Monotherapy with either angiotensin‐converting enzyme inhibitor or angiotensin receptor blocker
Number of subjects: 103
Study: 21438793

Group type: EXPERIMENTAL
Intervention: fenofibric acid + moderate-dose statin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: fenofibric acid + low-dose statin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: fenofibric acid + low- and moderate-dose statin
Number of subjects: 0
Study: 19130162

Group type: EXPERIMENTAL
Intervention: Cemented hemiarthroplasty
Number of subjects: 220

Group type: COMPARATOR
Intervention: Uncemented hemiarthroplasty
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Cemented and uncemented groups
Number of subjects: 220
Study: 16780234

Group type: EXPERIMENTAL
Intervention: HYB (hybrid program)
Number of subjects: 20

Group type: COMPARATOR
Intervention: WT (isotonic weight training)
Number of subjects: 20

Group type: COMPARATOR
Intervention: ES (isometric electrical stimulation)
Number of subjects: 20
Study: 15308255

Group type: EXPERIMENTAL
Intervention: Transplantation into prepared sockets
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (transplantation into fresh extraction site)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Transplantation with free bone autografts
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Transplantation after splitting osteotomy of the alveolar process
Number of subjects: 85
Study: 11296183

Group type: EXPERIMENTAL
Intervention: Propofol (n = 46)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Midazolam (n = 53)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Propofol (short sedation stratum, n = 21)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Midazolam (short sedation stratum, n = 26)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Propofol (long sedation stratum, n = 4)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Midazolam (long sedation stratum, n = 10)
Number of subjects: 99
Study: 9678089

Group type: EXPERIMENTAL
Intervention: Gracial (DSG/EE 7 x 25/40 micrograms/day + 15 x 125/30 micrograms/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Trigynon (LNG/EE 6 x 50/30 micrograms/day + 5 x 75/40 micrograms/day + 10 x 125/30 micrograms/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gracial (DSG/EE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Trigynon (LNG/EE)
Number of subjects: 20
Study: 8314411

Group type: EXPERIMENTAL
Intervention: Nicotinamide (1.2 g/m2 body surface)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31821997

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt containing Bifidobacterium lactis Bb12
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional yogurt
Number of subjects: 66
Study: 31577697

Group type: EXPERIMENTAL
Intervention: YGJT (3g twice a day for 4 weeks) + nutrition counseling
Number of subjects: 52

Group type: COMPARATOR
Intervention: Nutrition counseling
Number of subjects: 52
Study: 27324175

Group type: EXPERIMENTAL
Intervention: Deproteinized porcine bone mineral (DPBM)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Demineralized bovine bone mineral (DBBM)
Number of subjects: 16
Study: 26112886

Group type: EXPERIMENTAL
Intervention: LY518674 100 μg daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 23442225

Group type: EXPERIMENTAL
Intervention: VA (2000 IU daily retinol)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: VD (400 IU daily cholecalciferol)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: VAD (2000 IU daily retinol plus 400 IU cholecalciferol)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 400
Study: 21466079

Group type: EXPERIMENTAL
Intervention: Video condition (participants who watched a video of their precompetition preparation)
Number of subjects: 38

Group type: COMPARATOR
Intervention: No-video condition (players who did not watch a videotape)
Number of subjects: 38